Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Delineates Parameters...

Cambridge City Councilors Approve Psychedelics Decriminalization Measure

Tryp Therapeutics Launches Clinical Trials to Investigate Psilocybin for Over-Eating Disorders

Alberta’s First Full-Service Psychedelic Therapy Clinic Opens in Calgary, Ushering in...

Entheon Biomedical Hires Chief Business Officer; Senior Pharma Executive Dr. Brian...

PT231 – Dr. Hassan Tetteh – Human Care Over Health Care

MINDCURE’s Proprietary Bioinformatics Platform, PsyCollage, Beta Tested and Deployed for Product...

Tryp Therapeutics Reaches Milestone on Psilocybin Drug Manufacturing Program

Comparing 18-MC vs. Ibogaine for the Treatment of Substance Use Disorder

The Nuances of Ketamine’s Neurochemistry

Load more